The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs lowers celanese price target amid earnings concerns and high debt levels
UBS has lowered its price target for Celanese shares from $72 to $60, maintaining a neutral rating amid concerns over the company's earnings power and high debt levels. Despite a Q4 earnings beat, Celanese faces challenges, including a revenue shortfall and macroeconomic headwinds, prompting further downgrades from other analysts. The company is focusing on improving cash flow and addressing debt issues, with potential divestitures on the table.
deutsche bank maintains buy rating on celanese ahead of pivotal earnings report
Deutsche Bank has maintained a Buy rating on Celanese Corporation, anticipating a pivotal Q4 earnings report on February 18, which is expected to clarify the company's outlook under new CEO Scott Richardson. Despite a 47% decline in stock value over the past six months, analysts view the current trading price as attractive, with a P/E ratio of 7.26x, and foresee potential recovery in key markets. The company plans to reduce its quarterly dividend in early 2025 while focusing on cost management and operational excellence amidst ongoing macroeconomic challenges.
india medical plastics market projected to reach 38.20 billion by 2030
The Indian medical plastics market is projected to reach USD 38.20 billion by 2030, growing at a CAGR of 17.4% from 2025 to 2030, driven by increased healthcare spending and rising demand for medical devices. Rigid plastics dominate the market, holding over 70.9% of revenue in 2024, while soft plastics are expected to grow at the highest rate due to demand for various medical applications. However, challenges such as waste management and environmental concerns may hinder market growth.
celanese corporation shifts from buy to neutral rating by ubs
Celanese Corporation has shifted its rating from buy to neutral by UBS. The company focuses on chemicals and specialty materials, with net sales primarily from acetyl products (55.7%) and high-performance engineering polymers (44.3%). Geographically, the largest markets are the United States (25.8%), Germany (22.6%), and China (17.8%).
celanese corporation shifts from buy to neutral rating by ubS
Celanese Corporation has shifted its rating from buy to neutral by UBS. The company focuses on producing chemicals and specialty materials, with net sales primarily from acetyl products (55.7%) and high-performance engineering polymers (44.3%). Geographically, the largest markets include the United States (25.8%), Germany (22.6%), and China (17.8%).
institutional investors increase stakes in celanese amid mixed analyst ratings
Envestnet Portfolio Solutions Inc. increased its Celanese holdings by 45.8% in Q1, while SG Americas Securities LLC raised theirs by 229.3%. Analysts have downgraded Celanese's stock ratings, with UBS Group lowering its price target from $161 to $97, reflecting a consensus "Hold" rating among analysts. The company reported Q3 earnings of $2.44 per share, missing estimates, with revenue down 2.8% year-over-year.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.